Income Statement Evercore Inc.

Equities

EVR

US29977A1051

Investment Banking & Brokerage Services

Real-time Estimate Cboe BZX Other stock markets 01:09:04 13/02/2026 am IST			5-day change	1st Jan Change
322.34 ^USD	-6.72%		-8.59%	-5.67%

09:14pm	Julian Emanuel Sees FOMO Driving Market Staples 'Screaming Higher'	MT
09/02	Waters Corporation completed the acquisition of Biosciences and Diagnostics Solutions Business of Becton, Dickinson and Company in a transaction valued at $18.8 billion.	CI

7b16227b33c3e.zHufBSS_LsqQrHGEEvQFEVDPh9m-KyoxPEOaIvv2QdI.rh-oSRzceJX4mwvbd7Fyazf43eDVRV5Zfi3uc5quHrGTE8h3SuZ3hNPAFg

Published financial data: EVERCORE INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2020	2021	2022	2023	2024
Interest Expense, Total	2.14Cr	1.76Cr	1.68Cr	1.67Cr	1.68Cr
Net Interest Income	-2.14Cr	-1.76Cr	-1.68Cr	-1.67Cr	-1.68Cr
Asset Management Fee	5.44Cr	6.58Cr	6.45Cr	6.7Cr	7.96Cr
Underwriting & Investment Banking Fee	223.72Cr	320.45Cr	272.18Cr	227.77Cr	281.17Cr
Gain (Loss) on Sale of Investments, Total (Rev)	1.58Cr	3.02Cr	-2.72Cr	3.17Cr	3.44Cr
Other Revenues, Total	87.05L	22.21L	1.99Cr	6.62Cr	7.14Cr
Revenues Before Provison For Loan Losses	229.47Cr	328.51Cr	276.2Cr	242.59Cr	298.03Cr
Total Revenues	229.47Cr	328.51Cr	276.2Cr	242.59Cr	298.03Cr
Salaries And Other Employee Benefits	137.23Cr	184.88Cr	169.75Cr	165.69Cr	197.4Cr
Cost of Services Provided, Total	25Cr	26Cr	31Cr	34Cr	40Cr
Depreciation & Amortization - (IS) - (Collected)	2.62Cr	2.81Cr	2.77Cr	2.43Cr	2.45Cr
Other Operating Expenses	4.29Cr	4.06Cr	2.78Cr	4.11Cr	4.61Cr
Total Operating Expenses	169.03Cr	217.85Cr	206.29Cr	206.39Cr	244.54Cr
Operating Income	60Cr	110.66Cr	70Cr	36Cr	53Cr
Income (Loss) on Equity Invest.	1.44Cr	1.42Cr	79.99L	66.55L	62.31L
Currency Exchange Gains (Loss)	-	-	-	-	-7L
EBT, Excl. Unusual Items	62Cr	112.08Cr	71Cr	37Cr	54Cr
Restructuring Charges	-4.33Cr	-85.54L	-31.26L	-29.21L	-73.05L
Total Merger & Related Restructuring Charges	-6L	-7T	-	-	-
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) on Sale of Assets	-3.08Cr	-	-	-	-
Asset Writedown	-33.2L	-	-	-	-
Other Unusual Items	-	43.74L	-	-	-
EBT, Incl. Unusual Items	54Cr	111.66Cr	70Cr	37Cr	53Cr
Income Tax Expense	13Cr	25Cr	17Cr	8.06Cr	12Cr
Earnings From Continuing Operations	41Cr	87Cr	53Cr	29Cr	42Cr
Net Income to Company	41Cr	87Cr	53Cr	29Cr	42Cr
Minority Interest	-6.21Cr	-13Cr	-5.49Cr	-2.97Cr	-3.95Cr
Net Income - (IS)	35Cr	74Cr	48Cr	26Cr	38Cr
Net Income to Common Incl Extra Items	35Cr	74Cr	48Cr	26Cr	38Cr
Net Income to Common Excl. Extra Items	35Cr	74Cr	48Cr	26Cr	38Cr
Per Share Items
Net EPS - Basic	8.64	18.48	12.15	6.71	9.86
Basic EPS - Continuing Operations	8.64	18.48	12.15	6.71	9.86
Basic Weighted Average Shares Outstanding	4.06Cr	4.01Cr	3.92Cr	3.81Cr	3.84Cr
Net EPS - Diluted	8.22	17.08	11.61	6.37	9.08
Diluted EPS - Continuing Operations	8.22	17.08	11.61	6.37	9.08
Diluted Weighted Average Shares Outstanding	4.26Cr	4.33Cr	4.1Cr	4.01Cr	4.16Cr
Normalized Basic EPS	8.01	14.28	9.87	5.27	7.78
Normalized Diluted EPS	7.62	13.2	9.43	5.01	7.16
Dividend Per Share	2.35	2.72	2.88	3.04	3.2
Payout Ratio	30.4	16.05	26.71	50.05	35.91
Supplemental Items
Total Revenues (As Reported)	228.53Cr	330.71Cr	277.89Cr	244.27Cr	299.64Cr
Effective Tax Rate - (Ratio)	23.7	22.21	24.52	22.03	21.65
Current Domestic Taxes	9.4Cr	19Cr	13Cr	6.3Cr	8.18Cr
Current Foreign Taxes	2.04Cr	2.56Cr	4.07Cr	2.04Cr	2.56Cr
Total Current Taxes	11Cr	22Cr	17Cr	8.35Cr	11Cr
Deferred Domestic Taxes	1.05Cr	3.08Cr	50.38L	36.86L	2.26Cr
Deferred Foreign Taxes	32.9L	-17.57L	-58.93L	-65.8L	-1.45Cr
Total Deferred Taxes	1.38Cr	2.91Cr	-9L	-28.94L	80.74L
Normalized Net Income	32Cr	57Cr	39Cr	20Cr	30Cr
Supplemental Operating Expense Items
Stock-Based Comp., G&A Exp. (Total)	21Cr	22Cr	27Cr	30Cr	35Cr
Stock-Based Comp., Other (Total)	1.09Cr	-	-	-	-
Total Stock-Based Compensation	22Cr	22Cr	27Cr	30Cr	35Cr

Fiscal Period: December	2020	2021	2022	2023	2024
Assets
Cash And Equivalents	83Cr	58Cr	66Cr	60Cr	87Cr
Cash & Securities Segregated	-	-	-	-	-
Securities Owned	-	-	-	-	-
Securities Purchased Under Agreements To Resell	-	-	-	-	-
Accounts Receivable, Total	47Cr	45Cr	56Cr	55Cr	59Cr
Other Receivables	4L	5L	4L	3L	1L
Gross Property Plant And Equipment	56Cr	58Cr	57Cr	73Cr	74Cr
Accumulated Depreciation	-14Cr	-17Cr	-19Cr	-21Cr	-15Cr
Net Property Plant And Equipment	42Cr	41Cr	38Cr	52Cr	58Cr
Goodwill	13Cr	13Cr	12Cr	13Cr	12Cr
Other Intangibles, Total	7L	3L	-	-	-
Investment In Debt and Equity Securities	98Cr	150.91Cr	117.93Cr	122.8Cr	128.01Cr
Other Current Assets, Total	19Cr	36Cr	37Cr	33Cr	36Cr
Deferred Tax Assets Long-Term (Collected)	26Cr	25Cr	26Cr	27Cr	28Cr
Deferred Charges Long-Term	-	94.19L	1.14Cr	1.7Cr	1.81Cr
Other Long-Term Assets, Total	9.11Cr	10Cr	7.12Cr	7.34Cr	6.74Cr
Total Assets	337.09Cr	380.27Cr	362.09Cr	370.33Cr	417.4Cr
Liabilities
Accounts Payable, Total	3.8Cr	3.16Cr	2.88Cr	2.6Cr	2.9Cr
Accrued Expenses, Total	88Cr	110.97Cr	92Cr	76Cr	102.41Cr
Short-Term Borrowings	9L	-	-	-	-
Current Portion of Long-Term Debt	3.8Cr	-	-	-	3.8Cr
Current Portion of Leases	4.29Cr	4.73Cr	3.8Cr	3.63Cr	5.53Cr
Long-Term Debt	34Cr	38Cr	37Cr	37Cr	34Cr
Long-Term Leases	30Cr	30Cr	28Cr	43Cr	49Cr
Current Income Taxes Payable	1.53Cr	2.1Cr	98.42L	54.24L	47.81L
Unearned Revenue, Current	93.73L	92.57L	50.71L	35.24L	35.82L
Other Current Liabilities - (Brok / FS / Ins. / REIT Template)	4.1Cr	7.82Cr	7.04Cr	7.57Cr	7.51Cr
Unearned Revenue Non Current	1L	1L	-	-	-
Other Non Current Liabilities	18Cr	20Cr	17Cr	20Cr	17Cr
Total Liabilities	188.15Cr	216.74Cr	189.45Cr	192.08Cr	223.22Cr
Common Stock, Total	7L	7L	8L	8L	8L
Additional Paid In Capital	226.61Cr	245.88Cr	286.18Cr	316.32Cr	351.04Cr
Retained Earnings	80Cr	141.84Cr	176.81Cr	189.27Cr	213.39Cr
Treasury Stock	-182.47Cr	-254.55Cr	-306.59Cr	-345.32Cr	-390.14Cr
Comprehensive Income and Other	-97.58L	-1.21Cr	-2.79Cr	-2.65Cr	-3.61Cr
Total Common Equity	123.09Cr	132.04Cr	153.68Cr	157.69Cr	170.76Cr
Minority Interest	26Cr	31Cr	19Cr	21Cr	23Cr
Total Equity	148.94Cr	163.53Cr	172.64Cr	178.25Cr	194.18Cr
Total Liabilities And Equity	337.09Cr	380.27Cr	362.09Cr	370.33Cr	417.4Cr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	4.2Cr	3.84Cr	3.86Cr	3.87Cr	3.91Cr
ECS Total Common Shares Outstanding	4.08Cr	3.79Cr	3.83Cr	3.78Cr	3.81Cr
Book Value / Share	30.21	34.84	40.08	41.75	44.8
Tangible Book Value	110.11Cr	119.18Cr	141.35Cr	145.14Cr	158.32Cr
Tangible Book Value Per Share	27.02	31.44	36.86	38.42	41.54
Total Debt	72Cr	72Cr	69Cr	84Cr	92Cr
Net Debt	-11Cr	14Cr	2.44Cr	25Cr	5.03Cr
Equity Method Investments, Total	5.95Cr	5.86Cr	3.69Cr	3.69Cr	1.26Cr
Full Time Employees	1.78T	1.93T	2.1T	2.17T	2.38T
Part Time Employees	18	19.5	21.2	22	23.8

Fiscal Period: December	2020	2021	2022	2023	2024
Net Income	35Cr	74Cr	48Cr	26Cr	38Cr
Depreciation, Depletion & Amortization	2.51Cr	2.83Cr	2.83Cr	23.88L	-4L
Amortization of Goodwill and Intangible Assets - (CF)	16.05L	4L	3L	-	-
Total Depreciation, Depletion & Amortization	2.67Cr	2.87Cr	2.87Cr	23.88L	-4L
(Gain) Loss On Sale of Asset - (CF)	3.52Cr	12.5L	-	-	-
(Gain) Loss on Sale of Investments - (CF)	-86.81L	-2.42Cr	1.65Cr	-3.47Cr	-3.37Cr
Total Asset Writedown	33.2L	-	-	-	-
(Income) Loss On Equity Investments - (CF)	-16.36L	11.05L	30.38L	-2L	73.85L
Stock-Based Compensation (CF)	37Cr	42Cr	47Cr	52Cr	57Cr
Provision and Write-off of Bad Debts	68.78L	-60T	55.13L	55.59L	23.34L
Change in Accounts Receivable	-7.86Cr	1.6Cr	-4.61Cr	1.13Cr	-5.46Cr
Change in Accounts Payable	-8L	-54.97L	-10.93L	-10L	17.43L
Change In Income Taxes	1.19Cr	56.34L	-1.11Cr	-45.57L	-6L
Change in Other Net Operating Assets (Collected)	15Cr	13.88L	-50Cr	-36Cr	2.87Cr
Other Operating Activities	11Cr	20Cr	9.56Cr	6.9Cr	8.93Cr
Cash from Operations	98Cr	138.49Cr	53Cr	46Cr	99Cr
Capital Expenditure	-5.33Cr	-2.8Cr	-2.32Cr	-2Cr	-3.01Cr
Cash Acquisitions	-	-	-	-	-
Divestitures	7L	-	-	-	-
Investment in Marketable and Equity Securities, Total	-43Cr	-68Cr	34Cr	3.57Cr	-3.73Cr
Net (Increase) Decrease in Loans Originated / Sold - Investing	-	-	-	-	-
Other Investing Activities, Total	-	-	-	-	-
Cash from Investing	-48Cr	-71Cr	31Cr	1.56Cr	-6.74Cr
Short Term Debt Issued, Total	-	-	6.7Cr	-	-
Long-Term Debt Issued, Total	-	3.8Cr	-	-	-
Total Debt Issued	-	3.8Cr	6.7Cr	-	-
Short Term Debt Repaid, Total	-	-	-6.7Cr	-	-
Long-Term Debt Repaid, Total	-	-3.8Cr	-	-	-
Total Debt Repaid	-	-3.8Cr	-6.7Cr	-	-
Issuance of Common Stock	-	-	-	-	-
Repurchase of Common Stock	-15Cr	-73Cr	-55Cr	-39Cr	-45Cr
Common Dividends Paid	-11Cr	-12Cr	-13Cr	-13Cr	-14Cr
Common & Preferred Stock Dividends Paid	-11Cr	-12Cr	-13Cr	-13Cr	-14Cr
Other Financing Activities, Total	-5.38Cr	-7.69Cr	-5.8Cr	-3.74Cr	-4.22Cr
Cash from Financing	-31Cr	-93Cr	-74Cr	-56Cr	-63Cr
Foreign Exchange Rate Adjustments	76.31L	-46.16L	-2.43Cr	1.7Cr	-1.55Cr
Net Change in Cash	19Cr	-25Cr	8.48Cr	-6.66Cr	28Cr
Supplemental Items
Cash Interest Paid	2.37Cr	1.73Cr	1.69Cr	1.62Cr	1.62Cr
Cash Income Tax Paid (Refund)	11Cr	19Cr	22Cr	7.46Cr	9.82Cr
Net Debt Issued / Repaid	-	0	0	-	-

Fiscal Period: December	2020	2021	2022	2023	2024
Profitability
Return on Assets	13.83	24.22	14.32	7.79	10.61
Return On Equity %	31.55	55.59	31.62	16.26	22.43
Return on Common Equity	33.38	58.02	33.36	16.41	23.03
Margin Analysis
Gross Profit Margin %	95.91	97.23	95.54	93.88	94.16
SG&A Margin	66.56	61.46	68.22	76.26	73.84
Income From Continuing Operations Margin %	17.98	26.44	19.24	11.76	14.02
Net Income Margin %	15.28	22.53	17.25	10.53	12.69
Net Avail. For Common Margin %	15.28	22.53	17.25	10.53	12.69
Normalized Net Income Margin	14.15	17.41	14.01	8.27	10.01
Asset Turnover
Asset Turnover	0.77	0.92	0.74	0.66	0.76
Short Term Liquidity
Current Ratio	1.4	1.07	1.49	1.62	1.48
Quick Ratio	1.22	0.8	1.14	1.26	1.19
Operating Cash Flow to Current Liabilities	0.92	1.07	0.5	0.5	0.8
Long Term Solvency
Total Debt/Equity	48.38	44.09	39.84	47.37	47.55
Total Debt / Total Capital	32.6	30.6	28.49	32.14	32.23
LT Debt/Equity	42.89	41.2	37.64	45.34	42.75
Long-Term Debt / Total Capital	28.91	28.59	26.92	30.76	28.97
Total Liabilities / Total Assets	55.82	57	52.32	51.87	53.48
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	14.24	43.16	-15.92	-12.17	22.85
Gross Profit, 1 Yr. Growth %	17.51	45.13	-17.39	-13.69	23.21
Earnings From Cont. Operations, 1 Yr. Growth %	16.69	110.47	-38.82	-46.33	46.46
Net Income, 1 Yr. Growth %	17.87	111.12	-35.62	-46.39	48.07
Normalized Net Income, 1 Yr. Growth %	40.44	76.19	-32.33	-48.15	48.64
Diluted EPS Before Extra, 1 Yr. Growth %	19.3	107.79	-32.03	-45.13	42.54
Common Equity, 1 Yr. Growth %	41.53	7.26	16.39	2.61	8.29
Total Assets, 1 Yr. Growth %	29.72	12.81	-4.78	2.27	12.71
Tangible Book Value, 1 Yr. Growth %	49.48	8.23	18.61	2.68	9.08
Cash From Operations, 1 Yr. Growth %	93.85	41.55	-61.63	-13.82	115.78
Capital Expenditures, 1 Yr. Growth %	-24.69	-47.55	-17.1	-13.54	50.14
Dividend Per Share, 1 Yr. Growth %	4.91	15.74	5.88	5.56	5.26
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	5.42	27.88	9.71	-14.07	3.87
Gross Profit, 2 Yr. CAGR %	6.43	30.59	9.5	-15.56	3.12
Earnings From Cont. Operations, 2 Yr. CAGR %	-3.47	56.71	13.48	-42.7	-11.34
Net Income, 2 Yr. CAGR %	-3.6	57.74	16.59	-41.25	-10.9
Normalized Net Income, 2 Yr. CAGR %	7.27	57.3	12.18	-40.77	-12.21
Diluted EPS Before Extra, 2 Yr. CAGR %	-0.66	57.45	18.84	-38.93	-11.56
Common Equity, 2 Yr. CAGR %	27.42	23.21	11.74	9.28	5.41
Total Assets, 2 Yr. CAGR %	25.93	20.97	3.64	-1.32	7.37
Tangible Book Value, 2 Yr. CAGR %	33.66	27.19	13.3	10.36	5.83
Cash From Operations, 2 Yr. CAGR %	7.31	65.65	-26.3	-42.5	36.37
Capital Expenditures, 2 Yr. CAGR %	26.5	-37.15	-34.06	-15.34	13.94
Dividend Per Share, 2 Yr. CAGR %	11.21	10.19	10.7	5.72	5.41
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	11.96	16.74	11.2	1.87	-3.19
Gross Profit, 3 Yr. CAGR %	13.26	18.02	12.11	1.15	-4.23
Earnings From Cont. Operations, 3 Yr. CAGR %	32.05	25.17	14.54	-11.59	-21.65
Net Income, 3 Yr. CAGR %	40.85	25.19	17.01	-10.01	-20.05
Normalized Net Income, 3 Yr. CAGR %	20.98	26.57	18.74	-13.26	-19.51
Diluted EPS Before Extra, 3 Yr. CAGR %	43.19	27.04	19	-8.15	-18.99
Common Equity, 3 Yr. CAGR %	31.29	20.31	20.9	8.61	8.95
Total Assets, 3 Yr. CAGR %	28.6	21.39	11.69	3.18	3.15
Tangible Book Value, 3 Yr. CAGR %	41.32	24.58	24.26	9.64	9.93
Cash From Operations, 3 Yr. CAGR %	24.48	17.69	1.73	-22.36	-10.64
Capital Expenditures, 3 Yr. CAGR %	19.44	-5.67	-31.08	-27.83	2.48
Dividend Per Share, 3 Yr. CAGR %	18.28	12.7	8.74	8.96	5.57
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	13.41	17.93	11.05	3.28	8.21
Gross Profit, 5 Yr. CAGR %	14.23	19.25	11.74	3.23	8.42
Earnings From Cont. Operations, 5 Yr. CAGR %	48.22	42.37	24.28	-8.42	3.39
Net Income, 5 Yr. CAGR %	52.24	47.08	30.59	-7.5	4.93
Normalized Net Income, 5 Yr. CAGR %	26.79	34.04	16.12	-6.59	5.23
Diluted EPS Before Extra, 5 Yr. CAGR %	53.01	47.7	32.9	-5.22	5.68
Common Equity, 5 Yr. CAGR %	19.53	20.15	23.09	15.78	14.45
Total Assets, 5 Yr. CAGR %	17.91	18	17.97	11.74	9.94
Tangible Book Value, 5 Yr. CAGR %	29.95	28.74	29.36	18.68	16.53
Cash From Operations, 5 Yr. CAGR %	21.62	26.84	0.93	-11.63	14.38
Capital Expenditures, 5 Yr. CAGR %	26.93	8.69	-5.82	-9.66	-15.73
Dividend Per Share, 5 Yr. CAGR %	15.36	16.45	15.19	9.86	7.39